Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

sections

Report this comment to a moderator

Please fill in the form below if you think a comment is unsuitable. Please indicate which comment is of concern and why. Your comments will be sent to our moderator for review.

Report comment to moderator

MandatoryRequired fields.

Headline

'Patients could be seriously disadvantaged by Brexit, if we don’t get our act together'

Comment

The risk of a no-deal Brexit is growing but before then the Falsified Medicines Directive will affect all pharmacies in Europe, including the United Kingdom. The UK is also a major exporter of medicines and therefore the impact could be widespread. It is vital that patients here and across Europe continue to get their medicine, in the event of a no-deal scenario. Organisations in the medicine supply chain urgently need clarity about their responsibilities as well as support with implementing Brexit and the FMD. More specifically, they need guidance from experienced solution providers with traceability expertise. It is possible to build the requirements of the FMD into existing pharmacy workflows and this could be a great tool for patient safety and supply chain efficiency. With less than six months left for the industry to implement processes and systems to ensure FMD compliance, there is no time to waste, deal or no-deal. The post-Brexit world could get even more complicated, but whilst the mechanics of pack verification may change, the underlying rationale does not. - Mark Davison, Senior Operation Director, Europe - rfxcel

Posted date

23 AUG 2018

Posted time

16:00

Mandatory
Mandatory
Mandatory
Mandatory

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.